Quest Diagnostics , a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.80 per share, payable on July 21, 2025 to ...

Quest Diagnostics continues to stay on investors' radars due to its robust Advanced Diagnostics offerings and strength in acquisitions.

Function Health, the personal health platform known for democratizing lab testing, has acquired Ezra, an AI-powered medical imaging startup, in a strategic move that could transform preventive ...

Testing services company Labcorp has entered into an agreement to acquire certain clinical and anatomic pathology assets from Incyte Diagnostics ... has been on an acquisition spree recent ...

Function’s lab testing platform is available at all 2,200 Quest Diagnostics locations nationwide ... It seems the acquisition deal with Function will accelerate that process by making Ezra ...

Detailed price information for Lifemd Inc 8.875% Series A (LFMDP-Q) from The Globe and Mail including charting and trades.

Diagnostic service providers such as Quest and Labcorp have also benefited from deals to manage hospital labs as they seek market share gains. "We were not expecting any real fireworks here but ...

Quest Diagnostics Incorporated (NYSE ... mostly offset by the impact of the LifeLabs acquisition, which carries a lower revenue per requisition. On an organic basis, revenue per rec was up 3.6 ...

James Davis; Executive Chairman of the Board, President, Chief Executive Officer; Quest Diagnostics Inc Sam Samad; Chief Financial Officer, Executive Vice President; Quest Diagnostics Inc Welcome to ...

Quest Diagnostics Inc.’s stock rose 3% early Tuesday, after the company posted better-than-expected first-quarter earnings and backed its full-year guidance, but acknowledged the early part of ...